共 188 条
[1]
Natoli JL(2009)Global prevalence of chronic migraine: a systematic review Cephalalgia 30 599-609
[2]
Manack A(2015)Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options Clin Med 15 344-350
[3]
Dean B(2019)Current and emerging evidence-based treatment options in chronic migraine: a narrative review J Headache Pain 20 92-208
[4]
Diener H-C(2021)Calcitonin gene-related peptide monoclonal antibodies Versus Botulinum Neurotoxin a in the Preventive treatment of chronic migraine: an adjusted Indirect Treatment Comparison Meta-Analysis Front Pharmacol 12 803-803
[5]
Solbach K(2020)Botulinum Toxin in the Treatment of Headache Toxins (Basel) 12 201-1373
[6]
Holle D(2019)Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine BMJ Open 9 793-1472
[7]
Gaul C(2020)Impact of the botulinum-A toxin on prevention of adult migraine disorders J Integr Neurosci 19 1358-70
[8]
Agostoni EC(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 1465-859
[9]
Barbanti P(2011)OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program Headache 51 61-936
[10]
Calabresi P(2011)OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine Neurology 77 851-803